Todd C. Lee Md Mph Fidsa
Clinical trials sponsored by Todd C. Lee Md Mph Fidsa, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New combo therapy aims to beat staph blood infections Results expected Apr 2027 (estimated)
-
Could a common heart drug fight staph infections too?
Disease control Recruiting nowThis study looks at whether switching from aspirin to clopidogrel (another blood thinner) can reduce heart complications in people with a serious staph bloodstream infection. About 300 adults already taking aspirin for heart disease will be randomly assigned to stay on aspirin or…
Phase 4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Sep 21, 2026 21:00 UTC
-
New combo therapy aims to beat staph blood infections
Disease control Recruiting nowThis phase 2 trial tests whether adding the antibiotic ertapenem to standard cefazolin treatment improves outcomes for adults with methicillin-susceptible Staphylococcus aureus bloodstream infections. About 60 participants will receive either the combination or a placebo. The stu…
Phase 2 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Which antibiotic wins against MRSA in the blood? new trial aims to find out
Disease control Recruiting nowThis study compares two common antibiotics, daptomycin and vancomycin, to see which one works better for adults with MRSA bloodstream infections. About 300 participants will be randomly assigned to one of the two drugs. The goal is to find which treatment leads to fewer complicat…
Phase 4 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a lower dose of antibiotics be safer and just as effective for this lung infection?
Disease control Recruiting nowThis study is for people with a weakened immune system who have a serious lung infection called PCP. The standard treatment often causes bad side effects. Researchers want to see if a lower dose of the antibiotic TMP-SMX works just as well but with fewer side effects. About 416 a…
Phase 3 • Sponsor: Todd C. Lee MD MPH FIDSA • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC